Get complete Patent Opposition Report for Impax Laboratories

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Impax Laboratories's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3054929Aug 5, 2020Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof2
EP2234963Apr 8, 2020Controlled Release Formulations Of Levodopa And Uses Thereof4
EP3068396May 8, 2019Rapidly Disintegrating Formulations And Methods Of Use1